Effects of artificial cycles with and without gonadotropin-releasing hormone agonist pretreatment on frozen embryo transfer outcomes in patients with adenomyosis
Abstract Gonadotropin-releasing hormone agonist (GnRH-a) is generally added to the improve pregnancy outcomes of hormone replacement therapy cycles among patients with adenomyosis. We aimed to investigate whether adding GnRH-a can result in better pregnancy outcomes. This retrospective analysis incl...
Saved in:
Main Authors: | Muzi Li, Lihong Xu, Heng Zhao, Yanbo Du, Lei Yan |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/8ecc37e6769146729e4cf8da7ca7d35c |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Response to the gonadotropin releasing hormone agonist leuprolide in immature female sheep androgenized in utero
by: RECABARREN,SERGIO E, et al.
Published: (2005) -
Increased risk of pneumonia in patients receiving gonadotropin-releasing hormone agonists for prostate cancer.
by: Shiu-Dong Chung, et al.
Published: (2014) -
Effect of tamoxifen with or without gonadotropin-releasing hormone analog on DXA values in women with breast cancer
by: Eun Heui Kim, et al.
Published: (2021) -
Gonadotropin-releasing hormone agonists sensitize, and resensitize, prostate cancer cells to docetaxel in a p53-dependent manner.
by: Roberta M Moretti, et al.
Published: (2014) -
Endocrine and molecular milieus of ovarian follicles are diversely affected by human chorionic gonadotropin and gonadotropin-releasing hormone in prepubertal and mature gilts
by: Adam J. Ziecik, et al.
Published: (2021)